Metformin Use Was Associated With Reduced Risk of Incidental Sjögren's Syndrome in Patients With Type 2 Diabetes: A Population-Based Cohort Study
Purpose: Previous studies have shown that metformin exhibits an anti-inflammatory effect and may decrease the risk of incidental diabetes. But the effect of metformin on incidental Sjögren's syndrome is unknown. The aim of the study was to examine the association between metformin exposure and...
Main Authors: | Cheng-You Wang, Jung-Nien Lai, Chin-Hsiu Liu, Kai-Chieh Hu, Kai-Lun Sheu, James Cheng-Chung Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.796615/full |
Similar Items
-
Candida Infection as an Early Sign of Subsequent Sjögren's Syndrome: A Population-Based Matched Cohort Study
by: Chia-Lun Chen, et al.
Published: (2022-01-01) -
Association Between Endometriosis and Subsequent Risk of Sjögren’s Syndrome: A Nationwide Population-Based Cohort Study
by: Yung-Hsiang Chao, et al.
Published: (2022-05-01) -
Exposure to environmental air pollutants as a risk factor for primary Sjögren’s syndrome
by: Kevin Sheng-Kai Ma, et al.
Published: (2023-02-01) -
Metformin as a Treatment Strategy for Sjögren’s Syndrome
by: Joa Kim, et al.
Published: (2021-07-01) -
Risk of primary Sjogren’s Syndrome following human papillomavirus infections: a nationwide population-based cohort study
by: Huang-Hsi Chen, et al.
Published: (2022-08-01)